Prosecution Insights
Last updated: November 20, 2026

Kimberly Catherine Breen, USPTO Patent Examiner

Listed by the USPTO as BREEN, KIMBERLY CATHERINE

Tech Center 1600 • Art Units: 1651 1657 1675

This examiner grants 24% of resolved cases

Analysis

BREEN, KIMBERLY CATHERINE is assigned to Tech Center 1600 and Art Unit 1651. Across 85 resolved cases, the allowance rate is 23.5% and the interview lift is 54.4%. The median time to allowance is 1294 days. The low allowance outcome and higher interview measure suggest that interviews may be particularly important when navigating a difficult prosecution record.

The leading companies are Danisco US Inc., CJ CheilJedang Corporation, and B. G. Negev Technologies and Applications Ltd. The leading firms are Meunier Carlin & Curfman LLC, TROUTMAN PEPPER LOCKE LLP, and Nevrivy Patent Law Group P.L.L.C. The median duration supports early preparation for interviews and carefully sequenced claim amendments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

23.5%
Allow Rate
-36.5% vs TC avg
146
Total Applications
+54.4%
Interview Lift
1294
Avg Prosecution Days
Based on 85 resolved cases, 2023–2026

Rejection Statute Breakdown

9.7%
§101 Eligibility
9.2%
§102 Novelty
34.9%
§103 Obviousness
31.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18844384 MUTANT L-THREONINE-RELEASING PROTEIN AND METHOD FOR PRODUCING L-THREONINE USING SAME Non-Final OA CJ CHEILJEDANG CORPORATION
18023252 COMPOSITION FOR FREEZE-PRESERVING MICROALGAE BELONGING TO FAMILY THRAUSTOCHYTRIACEAE AND METHOD FOR FREEZE-PRESERVING OF MICROALGAE BELONGING TO THRAUSTOCHYTRIACEAE USING SAME Final Rejection CJ CHEILJEDANG CORPORATION
18681047 METHOD FOR PRODUCTION OF AMMONIA, USING INORGANIC NANOPARTICLE-MICROBIAL COMPLEX Final Rejection KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
17628903 WASHING AND CLEANING AGENTS HAVING IMPROVED ENZYME STABILITY Non-Final OA Henkel AG & Co. KGaA
16826135 POLYMERIC BIOCATALYSTS AND METHODS Final Rejection BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY
18002438 DIGITAL ANTIMICROBIAL SUSCEPTIBILITY TESTING Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18552599 Clostridial Neurotoxins Comprising an Exogenous Activation Loop Final Rejection IPSEN BIOPHARM LIMITED
18513092 AMINOACYL TRANSFER RNA SYNTHETASES Non-Final OA Trustees of Tufts College
18041975 BLOOD CELL LYSING AGENT FOR ISOLATING BACTERIA FROM BLOOD CULTURE Final Rejection Becton, Dickinson and Company
18566018 METHODS AND COMPOSITIONS RELATED TO A MODIFIED METHYLTRANSFERASE Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18284252 COLORIMETRIC BIOSENSOR, PREPARATION METHOD THEREOF, AND ANTIBIOTIC SUSCEPTIBILITY TESTING METHOD USING THE SAME Final Rejection INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
17172860 COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF Final Rejection Imagilin Technology LLC
18687521 LAUNDRY COMPOSITIONS FOR CLEANING Non-Final OA Danisco US Inc.
17774437 COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION IN BACILLUS CELLS Final Rejection DANISCO US INC.
18176270 METHODS AND KITS FOR DETECTING CROSS-CONTAMINATION IN FOODBORNE AND ENVIRONMENTAL PATHOGEN TESTING Non-Final OA Applied Food Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Kimberly Catherine Breen's allowance rate?

23.5% of resolved applications examined by Kimberly Catherine Breen were allowed (85 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.

Does an interview help with examiner Kimberly Catherine Breen?

This examiner's interview lift is +54.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Kimberly Catherine Breen take to allow a patent?

Applications allowed by Kimberly Catherine Breen took 1,294 days on average from filing to allowance.

Which art unit does examiner Kimberly Catherine Breen work in?

Kimberly Catherine Breen examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month